Sr. Accountant, R&D Finance
Sarepta Therapeutics | |
United States, Massachusetts, Cambridge | |
215 First Street (Show on map) | |
Mar 10, 2026 | |
|
Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to treat Duchenne. We're looking for people who see unlimited potential in themselves and who are motivated by an unwavering commitment to patients. What Sarepta Offers At Sarepta, we care deeply about all the people in our community and believe in the importance of supporting them in all aspects of their lives. We aspire to maintain a culture that acknowledges people bring their whole selves to work, and we will strive to help everyone in our community integrate their work and personal lives while maintaining productivity. We are committed to offering a range of benefits and work-life resources designed to support people in the following areas:
For a full list of our comprehensive benefits, see our website: https://www.sarepta.com/join-us The Importance of the Role The Senior Accountant, R&D Finance will report to the Manager, R&D Finance, and will be responsible for managing the accounting, budgeting, analysis, and reporting of various costs within the R&D organization. The Senior Accountant, R&D Finance will work closely with other Finance functions including Accounts Payable, External Reporting, and Procurement, as well as partnering with key members of the R&D organization (such as Clinical Operations, Research Operations, Regulatory Affairs, Business Development, and Medical Affairs), to help them achieve their goals as it relates to financial discipline. The Senior Accountant, R&D Finance will be a key individual contributor responsible for: supporting the R&D business unit by preparing quarterly forecasts and monthly accruals for various key areas of R&D activity, reporting expense information and relevant insights and analyses of actuals versus budget back to the R&D organization, and ensuring their responsible areas on the Company's financial statements are prepared timely and in accordance with generally accepted accounting principles on a monthly, quarterly, and annual basis. The successful candidate must have proven ability to thrive in a team environment, be willing to be a visible and active business partner for the functions they support, and demonstrate excellent time management in a hybrid work environment to meet various deadlines. They must also have proven to manage and maintain a variety of cross-functional relationships simultaneously in a fast-paced setting. The team particularly welcomes those with a curiosity to learn, interest in developing new skills, and desire to show initiative.The Opportunity to Make a Difference
More about You
What Now? We're always looking for solution-oriented, critical thinkers. So, if you're comfortable with ambiguity and candor, relish challenging yourself, and place kindness and integrity at the forefront of how you approach your peers and work, then we encourage you to apply. #LI-Hybrid Blank This position is hybrid, you will be expected to work on site at one of Sarepta's facilities in the United States and/or attend Company-sponsored in-person events from time to time. The targeted salary range for this position is $94,800 - $118,500 per year. Sarepta is making a good faith effort to be transparent and accurate around our hiring ranges. The salary offer is commensurate with Sarepta's compensation philosophy and considers factors including, but not limited to, education, training, experience, external market conditions, criticality of role, and internal equity. Candidates must be authorized to work in the U.S. Sarepta Therapeutics offers a competitive compensation and benefit package. Sarepta Therapeutics is an Equal Opportunity/Affirmative Action employer and participates in e-Verify. | |
Mar 10, 2026